HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 253-264 of 453
Drug study icon
RecruitingEUCTR 2022-001582-12

Open, multicenter, randomized clinical trial to evaluate the efficacy and safety of aripiprazole vs paliperidone / risperidone using multi-omics data in patients with a first psychotic episode.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Barcelona
SchizophreniaHistorical research record
Countries
Spain
Sponsor
Consorcio Centro de Investigacion Biomedica en Red (CIBER)
Drug study icon
RecruitingNCT07105111

Effectiveness of valbenazine in adults with tardive dyskinesia

Official study title

A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Multiple locations, including Bryant
Schizophrenia, Depression, ...Medication studyAges 18+
Countries
United States
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
RecruitingNCT04580134

CLOZAPINE Response in Biotype-1

Official study title

Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)

Multiple locations, including Hartford
Schizophrenia, BipolarityMedication studyAges 18–60
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Behavioral study icon
RecruitingNCT06898879

Enhancing Veteran-Clinical Collaboration in VA PRRCs

Official study title

Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation and Recovery Centers

In Albuquerque
Schizophrenia, Depression, ...Behavioural studyAges 18+
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Drug study icon
RecruitingNCT06740890

Exercise and Olanzapine-samidorphan

Official study title

A Proof of Concept Study of Time Limited Exercise Plus Olanzapine-samidorphan for the Prevention of Early Weight Gain

In New York
Schizophrenia, BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
New York State Psychiatric Institute
Other study type icon
RecruitingNCT07234708

Feeling Safe Study

Official study title

Feeling Safe: Feasibility and Acceptability Study Evaluating a New Psychological Intervention for People With Psychosis and Positive Delusional Symptoms

In Barcelona
SchizophreniaInterventional studyAges 18+
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Behavioral study icon
RecruitingNCT07085923

Norwegian Mental Illness Heart Health Study

Official study title

Dietary Counselling And Exercise To Combat Cardiovascular Disease Risk In Norwegian Patients With A Severe Mental Illness

In Oslo
Schizophrenia, BipolarityBehavioural studyAges 25–70
Countries
Norway
Sponsor
Madeleine Elisabeth Angelsen
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.